Showing 541-550 of 1775 results for "".
Introduction to Holistic Optometry
https://modernod.com/topics/nutritionpharmaceuticals/introduction-to-holistic-optometry/38607/Hear from several colleagues who specialize in this increasingly popular health care praxis.Pearls for Prism
https://modernod.com/topics/contact-lenses/pearls-for-prism/38837/Incorporating this feature into contact lenses may be the missing piece in some patients’ management plans.Modern Management Of Vitreous Opacities: Acquiring History And Performing A Thorough Clinical Examination
https://modernod.com/mod-issues/supplements-inserts/modern-management-of-vitreous-opacities-acquiring-history-and-performing-a-thorough-clinical-examination/38359/Part 1 of 2The Pink Eye
https://modernod.com/mod-issues/2019-june/the-pink-eye/39065/Why It’s Important to Have an OCT in Your Practice
https://modernod.com/topics/imagingdiagnostics/why-its-important-to-have-an-oct-in-your-practice/38718/This diagnostic device may require a clinician’s interpretation, but it enables the early detection of disease and can in some cases save a patient’s vision.Early IOP Spike Post Cataract Surgery?
https://modernod.com/articles/significant-findings/early-iop-spike-post-cataract-surgery/37770/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatA Case of MEWDS
https://modernod.com/topics/retina/a-case-of-mewds/38893/This condition typically has a good prognosis, usually requiring only observation.The Monthly MOD Report
https://modernod.com/mod-issues/2023-may-june/the-monthly-mod-report-2/38638/Global Perspectives with Behrad Garmsiri
https://modernod.com/mod-issues/2022-sept/global-perspectives-with-behrad-garmsiri/38484/Consensus Panel Highlights: Pharmacotherapy for Presbyopia and Considerations for the Posterior Segment
https://modernod.com/programs/cme/Consensus-Panel-Highlights-Pharmacotherapy-for-Presbyopia-and-Considerations-for-the-Posterior-Segment/36580/This supplement summarizes a panel discussion among optometrists and retina specialists who convened to discuss the expanding armamentarium of presbyopia-correcting eye drops and establish a set of best practices regarding diagnostic testing, patient candidacy, and follow-up regimens.